Characteristics | Number of patients | P-valuea | |
---|---|---|---|
High MFAP5 expression | Low MFAP5 expression | ||
Gender | 1.000 | ||
Female | 49 | 46 | |
Male | 58 | 55 | |
Age | 0.581 | ||
>58 | 53 | 46 | |
≤ 58 | 54 | 55 | |
Tumor | 0.7815 | ||
>5 cm | 55 | 49 | |
≤ 5 cm | 52 | 52 | |
Tumor number | 0.473 | ||
single | 69 | 77 | |
Multiple | 38 | 34 | |
Tumor differentiation | 0.477 | ||
Well | 4b | 5 | |
Moderate | 64 | 67 | |
Poor-undifferentiated | 39 | 29 | |
Vascular invasion | 0.720 | ||
Not present | 86 | 84 | |
Present | 21 | 17 | |
Lymph node invasion | 0.0001 | ||
Not present | 67 | 89 | |
Present | 40 | 12 | |
AJCC 8th TNM stage | 0.006 | ||
I | 35 | 31 | |
II | 17 | 35 | |
III | 27 | 16 | |
IV | 28 | 15 | |
3-year survival | 0.058 | ||
≥ 36 months | 16 | 26 | |
<36 months | 91 | 75 | |
5-year survival rate | 0.030 | ||
≥ 60 months | 5 | 14 | |
<60 months | 102 | 87 |